Abstract
Recombinant hepatitis B surface antigen (rHBsAg) particles, secreted from Chinese hamster ovary (CHO) cells stably transfected with the S gene of HBV, are indistinguishable antigenically from HBsAg particles derived from the plasma of patients chronically infected with hepatitis B virus (HBV). The recombinant vaccine containing CHO cell derived rHBsAg is more immunogenic in chimpanzees than previously reported vaccines of either plasma derived HBsAg or yeast derived rHBsAg based on the kinetics of antibody production and the maximum titers elicited. In addition, chimpanzees vaccinated with CHO cell–culture derived vaccine have a strong cellular immune response to rHBsAg as measured by cell proliferation assays. Animals vaccinated with cell culture derived rHBsAg (ad subtype) are protected from infection with both the ad and ay subtypes of HBV.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McAuliffe, V.J., Purcell, R.H., and Gerin, J.L. 1980. Type B Hepatitis: A review of current prospects for a safe and effective vaccine. Rev. Infec. Dis. 2:470–492.
Szmuness, W., Stevens, C.E., Zang, E.A., Harley, E.J. Kellner, A. 1981. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): A final report. Hepatology 1:377.
Francis, D.P., Hadler, S.C., Thompson, S.E., Maynard, et al. 1982. Prevention of Hepatitis B with Vaccine: Report of the Centers for Disease control multi-center efficacy trial among homosexual men. 97:362–366.
Valenzuela, P., Medina, A., Rutter, W.J., Ammerer, G., and Hall, B.D., 1982. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298:347–350.
Hitzeman, R.A., Chen, C.Y., Hagie, F.E., Patzer, et al. 1983. Expression of hepatitis B virus surface antigen in yeast. Nuc. Acids Res. 11:2745–2763.
Moriarty, A.M., Hoyer, B.H., Shih, J.W., Gerin, J.L., and Hamer, D.H. 1981. Expression of the hepatitis B virus surface antigen gene in cell culture by using a simian virus 40 vector. Proc. Natl. Acad. Sci., USA 78:2606–2610.
Pourcel, C., Sobzack, E., Dubois, M-F., Gervais, M., Drouet, J., and Tiollais, P. 1982. Antigenicity and immunogenicity of hepatitis B virus particles produced by mouse cells transfected with cloned viral DNA. Virol. 121:175–183.
Liu, C.C., Yansura, D., and Levinson, A.D. 1982. Direct expression of hepatitis B surface antigen in monkey cells from an SV40 vector. DNA 1:213–221.
Dubois, M.F., Pourcel, C., Rousset, S., Chany, C., and Tiollais, P. 1980. Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA. Proc. Natl. Acad. Sci. USA 77:4549–4553.
Christman, J.K., Gerber, M., Price, P.M., Flordellis, C., Edelman, J., and Acs, G. 1982. Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA. Proc. Natl. Acad. Sci. USA 79:1815–1819.
Michel, M-L., Sobczak, E., Malpiece, Y., Tiollais, P., and Streek, R.E. 1985. Expression of amplified hepatitis B virus surface antigen genes in Chinese Hamster Ovary cells. BioTechnology 3:561–566.
Fujisawa, T., Ito, Y., Sasada, R., Ono, Y. et al. 1983. Direct expression of hepatitis B surface antigen gene in E. coli. Nuc. Acids Res. 11:3581–3591.
Patzer, E.J., Gregory, T.J., Nakamura, G.R., Simonsen, C.C. et al. 1985. Recombinant hepatitis B surface antigen vaccine from a continuous cell line, p. 261–264. Vaccines 85; In: Molecular and Chemical Basis of Resistance to Parasitic, Bacterial, and Viral Disease. Lerner and Chanock (eds.), Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
Patzer, E.J., Gregory, T.J., Nakamura, G.R., Hershberg, R.D., Gregory, T.J., and Levinson, A.D. 1984. Characterization of recombinant-derived hepatitis B surface antigen secreted by a continuous cell line, pp. 477–485. In: Viral Hepatitis and Liver Disease. Vyas, Dienstag and Hoofnagel (eds.). Grune and Stratton, Inc., Orlando, FL.
Urlaub, G., and Chasin, L.A. 1980. Isolation of Chinese Hamster cell mutants deficient in dihydrofolate reductase activity. Proc. Natl. Acad. Sci., USA 77:4216–4220.
Simonsen, C.C., and Levinson, A.D. 1983. Isolation and expression of an altered mouse dihydrofolate reductase cDNA. Proc. Natl. Acad. Sci., USA 80:2495–2499.
Cupps, T.R., Gerin, J.L., Purcell, R.H., Goldsmith, P.K., and Fauci, A.S. 1984. In vitro antigen-induced antibody responses to hepatitis B surface antigen in man: kinetic and cellular requirements. J. Clin. Invest. 74:1204–1213.
Celis, E., Kung, P.C., Chang, T.W. 1984. Hepatitis B virus-reactive human T lymphocyte clones: antigen specificity and helper function for antibody synthesis. J. Immunol. 132:1511–1515.
Tabor, E., Purcell, R.H., London, W.T., and Gerety, R.J. 1983. Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers. J. Infect. Dis. 147:531–534.
Brotman, B., Prince, A.M., Huima, T., Richardson, L., van den Ende, M.C., and Pfeifer, U. 1983. Interference between non-A, non-B and hepatitis B virus infection in chimpanzees. J. Med. Virol. 11:191–205.
Hollinger, F.B., Dolana, G., Thomas, W., and Gyorkey, F. 1984. Reduction in risk of hepatitis transmission by heat-treatment of a human factor VIII concentrate. J. Infect. Dis. 150:250–262.
Hilleman, M.R., Buynak, E.B., McAleer, W.J., McLean, A.A., Provost, P.J., and Tytell, A.A. 1981. Hepatitis A and hepatitis B vaccines, p. 385–397. In: Viral Hepatitis 1981 International Symposium. Szmuness, Alter and Maynard (eds.). The Franklin Press.
Imai, M., Yanase, Y., Nojiri, T., Miyakawa, Y., and Mayumi, M. 1979. Gastroenterology 76:242.
Machida, A., Kishimoto, S., Ohnuma, H., Baba, K. et al. 1984. A polypeptide containing 55 amino acid residues coded by the pre-S region of hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology 86:910–918.
McAleer, W.J., Buynak, E.B., Maigetter, R.Z., Wampler, D.E., Miller, W.J., and Hilleman, M.R. 1984. Human hepatitis B vaccine from recombinant yeast. Nature 307:178–180.
Chang, T.W., Celis, E., Miller, R.W., Zurawaski, Jr., V.R., Kung, P.C. 1984. In vitro response to HBsAg of peripheral blood lymphocytes from recipients of hepatitis B vaccine. Hepatology 4:824–829.
Gerety, R.J., Tabor, E., Purcell, R.H., and Tyeryar, F.J. 1979. From the National Institute of Allergy and Infectious Diseases: Summary of an international workshop on hepatitis B vaccine. J. Inf. Dis. 140:642–648.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Patzer, E., Nakamura, G., Hershberg, R. et al. Cell Culture Derived Recombinant HBsAg is Highly Immunogenic and Protects Chimpanzees from Infection with Hepatitis B Virus. Nat Biotechnol 4, 630–636 (1986). https://doi.org/10.1038/nbt0786-630
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0786-630